AMJ Global Technology SEC 10-Q Report

About this update from Amj Global Technology

AMJ Global Technology, a company focused on developing mobile software products with an emphasis on the intersection of technology and holistic health treatments, has released its Form 10-Q report for the quarter ended May 31, 2025. The report provides a detailed overview of the company's financial performance and key business activities during the period. Financial Highlights Revenue: $0. The company did not generate any operating revenues during the three and six months ended May 31, 2025, and 2024. Operating Loss: $68,017 for the three months ended May 31, 2025, compared to $45,094 for the same period in 2024, reflecting an increase in operating expenses. Net Income (Loss): $(79,052) for the three months ended May 31, 2025, compared to $53,015 for the same period in 2024, primarily due to the absence of a gain on settlement of debt-related party and increased operating expenses. Net Income (Loss): $(134,414) for the six months ended May 31, 2025, compared to $3,341 for the same period in 2024, due to increased operating expenses and interest expenses. Basic and Diluted Income (Loss) Per Common Share: $(0.00) for the three months ended May 31, 2025, compared to $0.00 for the same period in 2024, reflecting the net loss incurred. Business Highlights Business Focus: AMJ Global Technology is focused on developing mobile software products, with an emphasis on the intersection of technology and holistic health treatments. The company aims to address the needs of professional athletes suffering from PTSD and early onset dementia and Alzheimer's. Intellectual Property Acquisition: On April 26, 2023, AMJ Global Technology acquired 25% ownership rights to the 'Blabeey' platform from AMJ Global Entertainment, LLC, which includes software, code, and trade secrets. Software and Technology Asset Termination: On May 7, 2025, the company terminated its agreement with Dataark Systems LLC regarding the ElephantSqlDB® database software, resulting in the cancellation of 1,333,333 shares of common stock. Revenue Sharing Agreement: The company entered into a revenue-sharing agreement with Dark Bull Capital, Inc., a related party, to receive 5% of net revenue from contracts related to Medicare enrollees and insurance sales. Equity Investment: AMJ Global Technology acquired a 30% equity stake in a company controlled by a related party, providing the company with significant influence over its operations and financial policies. Future Outlook: The company is evaluating operations in the holistic health industry, focusing on revenue sharing from Medicare enrollees and insurance sales, which is expected to generate revenue and cash flow. Going Concern: The company has been issued a 'going concern' opinion due to its reliance on related party advances and the sale of common stock as the primary source of funding for operations. SEC Filing:

View stock analysis, news, and events for Amj Global Technology